SCHEMBL6100367

SCHEMBL6100367

COc1cc(CC(=O)Nc2ccc(OC(F)(F)F)c(-c3ccccc3)c2)ccc1OCCN

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 1/20 0.51
NPSR1 Q6W5P4 4/20 0.50
ALDH1A1 P00352 3/20 0.50
MAPT P10636 3/20 0.50
HSD17B10 Q99714 3/20 0.50
KDM4E B2RXH2 2/20 0.50
HPGD P15428 2/20 0.50
POLB P06746 1/20 0.50
RXFP1 Q9HBX9 1/20 0.50
EPHX2 P34913 1/20 0.49
SMN1; SMN2 Q16637 5/20 0.49
LMNA P02545 4/20 0.49
HTT P42858 4/20 0.49
KMT2A Q03164 2/20 0.49
TSHR P16473 2/20 0.49
MAPK1 P28482 2/20 0.49
MEN1 O00255 1/20 0.49
BCHE P06276 2/20 0.48
ACHE P22303 2/20 0.48
RORC P51449 7/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6100193 0.87 ALDH1A1 (0.53) KDRNPSR1ALDH1A1MAPTHSD17B10
SCHEMBL6099858 0.86 KDM4E (0.54) KDRNPSR1ALDH1A1MAPTHSD17B10
SCHEMBL6100336 0.84 SMN1; SMN2 (0.60) KDRNPSR1ALDH1A1MAPTHSD17B10
SCHEMBL6102257 0.84 SMN1; SMN2 (0.53) KDRNPSR1ALDH1A1MAPTHSD17B10
SCHEMBL6101654 0.83 SMN1; SMN2 (0.63) KDRNPSR1ALDH1A1MAPTHSD17B10
Hydrochloric Acid SCHEMBL6099402 0.82 SMN1; SMN2 (0.62) KDRNPSR1ALDH1A1MAPTHSD17B10
SCHEMBL6100605 0.82 SMN1; SMN2 (0.62) KDRNPSR1ALDH1A1MAPTHSD17B10
SCHEMBL6101421 0.81 SMN1; SMN2 (0.52) KDRNPSR1ALDH1A1MAPTHSD17B10
SCHEMBL6100141 0.81 LMNA (0.49) KDRNPSR1ALDH1A1MAPTHSD17B10
SCHEMBL6099067 0.81 SMN1; SMN2 (0.55) KDRNPSR1ALDH1A1MAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7084176-B2 N-arylphenylacetamide derivatives and medicinal compositions containing the same DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2006-08-01 US claimed
US-20040248983-A1 N-arylphenylacetamide derivatives and medicinal compositions containing the same DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2004-12-09 US claimed
EP-1403235-A1 N-ARYLPHENYLACETAMIDE DERIVATIVES AND MEDICINAL COMPOSITIONS CONTAINING THE SAME Dainippon Pharmaceutical Co., Ltd. (JP) 2004-03-31 EP claimed
US-7084176-B2 N-arylphenylacetamide derivatives and medicinal compositions containing the same DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2006-08-01 US disclosed
US-20040248983-A1 N-arylphenylacetamide derivatives and medicinal compositions containing the same DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2004-12-09 US disclosed
EP-1403235-A1 N-ARYLPHENYLACETAMIDE DERIVATIVES AND MEDICINAL COMPOSITIONS CONTAINING THE SAME Dainippon Pharmaceutical Co., Ltd. (JP) 2004-03-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040248983-A1 N-arylphenylacetamide derivatives and medicinal compositions containing the same HRH2, CCR8, CYP2C8 KDR 4075/4885NPSR1 808/4885ALDH1A1 684/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.